131 related articles for article (PubMed ID: 22178718)
1. An Epstein-Barr virus-associated leukemic lymphoma in a patient treated with rabbit antithymocyte globulin and cyclosporine for hepatitis-associated aplastic anemia.
Ohata K; Iwaki N; Kotani T; Kondo Y; Yamazaki H; Nakao S
Acta Haematol; 2012; 127(2):96-9. PubMed ID: 22178718
[TBL] [Abstract][Full Text] [Related]
2. [Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis subsequent to rabbit antithymocyte globulin administration and successfully treated with rituximab in a patient with aplastic anemia].
Nagata H; Fujino T; Muramatsu A; Kawaji Y; Kuriyama K; Oshiro M; Hirakawa Y; Iwai T; Uchiyama H
Rinsho Ketsueki; 2018; 59(4):407-413. PubMed ID: 29743400
[TBL] [Abstract][Full Text] [Related]
3. Occurrence of Epstein-Barr virus-associated plasmacytic lymphoproliferative disorder after antithymocyte globulin therapy for aplastic anemia: a case report with review of the literature.
Nakanishi R; Ishida M; Hodohara K; Okuno H; Yoshii M; Horinouchi A; Shirakawa A; Harada A; Iwai M; Yoshida K; Kagotani A; Yoshida T; Okabe H
Int J Clin Exp Pathol; 2014; 7(4):1748-54. PubMed ID: 24817974
[TBL] [Abstract][Full Text] [Related]
4. Reactivation and dynamics of cytomegalovirus and Epstein-Barr virus after rabbit antithymocyte globulin and cyclosporine for aplastic anemia.
Park SS; Cho SY; Han E; Min GJ; Park S; Yoon JH; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Kim HJ; Min CK; Cho SG; Lee JW
Eur J Haematol; 2019 Oct; 103(4):433-441. PubMed ID: 31381187
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr Virus-associated Lymphoproliferative Disorder with Encephalitis Following Anti-thymocyte Globulin for Aplastic Anemia Resolved with Rituximab Therapy: A Case Report and Literature Review.
Mashima K; Yano S; Yokoyama H; Saito T; Machishima T; Shimada T; Yahagi Y; Takahara S; Sugiyama K; Ogasawara Y; Minami J; Kamiyama Y; Katsube A; Suzuki K; Ohshima S; Yamada H; Usui N; Aiba K
Intern Med; 2017; 56(6):701-706. PubMed ID: 28321074
[TBL] [Abstract][Full Text] [Related]
6. Rapidly progressive Epstein-Barr virus-associated lymphoproliferative disorder unpredictable by weekly viral load monitoring.
Wakabayashi S; Ohashi K; Hanajiri R; Kobayashi T; Yamashita T; Akiyama H; Sakamaki H
Intern Med; 2010; 49(10):931-5. PubMed ID: 20467179
[TBL] [Abstract][Full Text] [Related]
7. High fatality rate of Epstein-Barr virus-associated lymphoproliferative disorder occurring after bone marrow transplantation with rabbit antithymocyte globulin conditioning regimens.
Peres E; Savasan S; Klein J; Abidi M; Dansey R; Abella E
J Clin Microbiol; 2005 Jul; 43(7):3540-3. PubMed ID: 16000501
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus-associated lymphoproliferative disorder developed after anti-thymocyte globulin therapy in a patient with bone marrow failure associated with T-cell large granular lymphocytic leukemia.
Sumi M; Watanabe M; Sato K; Shimizu I; Ueki T; Akahane D; Ueno M; Ichikawa N; Asano N; Kobayashi H
Rinsho Ketsueki; 2011 Nov; 52(11):1782-7. PubMed ID: 22185802
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus-related lymphoproliferative disorder induced by equine anti-thymocyte globulin therapy.
Viola GM; Zu Y; Baker KR; Aslam S
Med Oncol; 2011 Dec; 28(4):1604-8. PubMed ID: 20680523
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus reactivation in a patient treated with anti-thymocyte globulin for severe aplastic anemia.
Calistri E; Tiribelli M; Battista M; Michelutti A; Corbellino M; Viale P; Fanin R; Damiani D
Am J Hematol; 2006 May; 81(5):355-7. PubMed ID: 16628717
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus-induced polyclonal lymphoproliferative disorder of lymphoplasmacytic type in an autopsy case of aplastic anemia treated twice with anti-thymocyte globulin therapy.
Okada E; Shigeyasu H; Inaguma Y; Emi N; Sano K; Tsutsumi Y
Pathol Int; 2015 May; 65(5):274-6. PubMed ID: 25677466
[No Abstract] [Full Text] [Related]
12. Successful Treatment of Epstein-Barr Virus-Associated Lymphoproliferative Disorder with Rituximab in a Patient Undergoing Immunosuppressive Therapy for Aplastic Anemia.
Shimizu H; Kobayashi N; Mihara M; Iriuchishima H; Ishizaki T; Kojima Y; Handa H
Acta Haematol; 2016; 136(3):174-7. PubMed ID: 27561697
[TBL] [Abstract][Full Text] [Related]
13. Aplastic Anemia with Epstein-Barr Virus Reactivation after Anti-thymocyte Globulin Therapy.
Kawarada Y; Hara R; Kitahara T; Numata H; Watanabe S; Yamada M; Ando K
Intern Med; 2023 Sep; 62(17):2553-2557. PubMed ID: 36725050
[TBL] [Abstract][Full Text] [Related]
14. Distinct EBV and CMV reactivation patterns following antibody-based immunosuppressive regimens in patients with severe aplastic anemia.
Scheinberg P; Fischer SH; Li L; Nunez O; Wu CO; Sloand EM; Cohen JI; Young NS; John Barrett A
Blood; 2007 Apr; 109(8):3219-24. PubMed ID: 17148582
[TBL] [Abstract][Full Text] [Related]
15. Molecular quantification of viral load in plasma allows for fast and accurate prediction of response to therapy of Epstein-Barr virus-associated lymphoproliferative disease after allogeneic stem cell transplantation.
van Esser JW; Niesters HG; Thijsen SF; Meijer E; Osterhaus AD; Wolthers KC; Boucher CA; Gratama JW; Budel LM; van der Holt B; van Loon AM; Löwenberg B; Verdonck LF; Cornelissen JJ
Br J Haematol; 2001 Jun; 113(3):814-21. PubMed ID: 11380475
[TBL] [Abstract][Full Text] [Related]
16. Plasmacytic hyperplasia in age-related Epstein-Barr virus-associated lymphoproliferative disorders: a report of two cases.
Kojima M; Morita Y; Nakamura N; Shimizu K; Murayama K; Nakamura S
Pathol Res Pract; 2008; 204(4):267-72. PubMed ID: 18187262
[TBL] [Abstract][Full Text] [Related]
17. Features of Epstein-Barr Virus (EBV) reactivation after reduced intensity conditioning allogeneic hematopoietic stem cell transplantation.
Peric Z; Cahu X; Chevallier P; Brissot E; Malard F; Guillaume T; Delaunay J; Ayari S; Dubruille V; Le Gouill S; Mahe B; Gastinne T; Blin N; Saulquin B; Harousseau JL; Moreau P; Milpied N; Coste-Burel M; Imbert-Marcille BM; Mohty M
Leukemia; 2011 Jun; 25(6):932-8. PubMed ID: 21350556
[TBL] [Abstract][Full Text] [Related]
18. Successful Allogeneic Stem Cell Transplantation for Severe Aplastic Anemia after Treatment of Lymphoproliferative Disorder Caused by Rabbit Antithymocyte Globulin.
Tsukamoto S; Nagao Y; Yamazaki A; Sugita Y; Muto T; Sakai S; Takeda Y; Mimura N; Takeuchi M; Ohwada C; Sakaida E; Yokote K; Iseki T; Nakaseko C
Intern Med; 2015; 54(24):3197-200. PubMed ID: 26666612
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic trials for a rabbit model of EBV-associated Hemophagocytic Syndrome (HPS): effects of vidarabine or CHOP, and development of Herpesvirus papio (HVP)-negative lymphomas surrounded by HVP-infected lymphoproliferative disease.
Hayashi K; Joko H; Koirala TR; Onoda S; Jin ZS; Munemasa M; Ohara N; Oda W; Tanaka T; Oka T; Kondo E; Yoshino T; Takahashi K; Yamada M; Akagi T
Histol Histopathol; 2003 Oct; 18(4):1155-68. PubMed ID: 12973684
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disorders.
Park S; Ko YH
J Dermatol; 2014 Jan; 41(1):29-39. PubMed ID: 24438142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
